<i>Breakfast with Benjamin</i> Based on their own rhetoric, this is how Hillary Clinton and Donald Trump would impact your wallet, if they win the White House.
The firm is selling a majority stake of NFP Advisor Services to funds managed by private equity shop Stone Point Capital.
Plus: Gold is investing in monetary chaos, corporate bonds fly off the shelves, and more fuzzy employment math
Invest in Others and <i>InvestmentNews</i> recognize charitable works of advisers and corporate programs for employees.
Operating income declined 1% on reduced client activity and lower mutual fund fees
A new study shows more Americans are getting their financial acts together. But are they getting smarter or just a little wealthier thanks to a stronger economy?
Financial advisers say it's crucial to get investors to stay focused on diversification, dividends and their long-term goals.
The national advisory firm works with institutional clients such as defined-contribution and traditional pension plans.
First-quarter profit nearly double what the company posted in the previous quarter.
Brent Brodeski of Savant Capital explains how his firm helps clients plan to pass on their money and values, and the upshot of doing so for advisers.
Invest in Others and <i>InvestmentNews</i> announce five financial advisers and one firm honored for making a difference with philanthropic giving and service.
He cuts a much lower profile and his comments about the market are filled with introspection.
Registered investment advisory firms have been merging at swift pace after record-setting 2015
Oil has risen about 19% since closing below $40 a barrel and slipping into a bear market earlier this month.
The independent broker-dealer is paying restitution for failing to waive sales charges for some retirement plans and charitable organizations, according to Finra.
WestPark Capital CEO Richard Rappaport says Newport Coast Securities is closing and that he is being selective in who he hires from the broker-dealer.
His departure follows agreement to be bought by Fortress Biotech.
